| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | BIO-TECHNE Corp | 18,228,210 | 11.5% | EDGAR |
| SC 13G/A | 2024-01-24 | BlackRock Inc. | BIO-TECHNE Corp | 18,133,912 | 11.5% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | BIO-TECHNE Corp | 18,199,432 | 11.6% | EDGAR |
| SC 13G/A | 2023-01-26 | BlackRock Inc. | BIO-TECHNE Corp | 15,888,640 | 10.1% | EDGAR |
| SC 13G | 2023-01-20 | BlackRock Inc. | BIO-TECHNE Corp | 15,888,640 | 10.1% | EDGAR |
| SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | BIO-TECHNE Corp | 4,426,638 | 11.3% | EDGAR |
| SC 13G/A | 2022-01-27 | BlackRock Inc. | BIO-TECHNE Corp | 4,328,299 | 11.0% | EDGAR |
| SC 13G/A | 2022-01-25 | BlackRock Inc. | BIO-TECHNE Corp | 4,328,299 | 11.0% | EDGAR |
| SC 13G/A | 2021-09-10 | VANGUARD GROUP INC | BIO-TECHNE Corp | 4,315,543 | 11.0% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | BIO-TECHNE Corp | 3,591,352 | 9.3% | EDGAR |
| SC 13G/A | 2021-01-27 | BlackRock Inc. | BIO-TECHNE Corp | 4,348,028 | 11.3% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | BIO-TECHNE Corp | 3,568,802 | 9.4% | EDGAR |
| SC 13G/A | 2020-02-10 | BlackRock Inc. | BIO-TECHNE Corp | 3,840,097 | 10.0% | EDGAR |
| SC 13G/A | 2020-02-04 | BlackRock Inc. | BIO-TECHNE Corp | 3,811,161 | 10.0% | EDGAR |
| SC 13G/A | 2019-04-15 | BIO-TECHNE Corp | ChemoCentryx, Inc. | 3,987,654 | 7.2% | EDGAR |
| SC 13G/A | 2019-02-14 | BROWN CAPITAL MANAGEMENT LLC | BIO-TECHNE Corp | 1,702,424 | 4.5% | EDGAR |
| SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | BIO-TECHNE Corp | 3,443,749 | 9.1% | EDGAR |
| SC 13G/A | 2019-01-24 | BlackRock Inc. | BIO-TECHNE Corp | 3,855,948 | 10.2% | EDGAR |
| SC 13G/A | 2018-07-10 | BlackRock Inc. | BIO-TECHNE Corp | 3,776,455 | 10.1% | EDGAR |
| SC 13G/A | 2018-02-14 | Select Equity Group, L.P. | BIO-TECHNE Corp | 1,339,760 | 3.6% | EDGAR |